Small-molecule anti-COVID-19 drugs and a focus on China’s homegrown mindeudesivir (VV116)

{{article.zuoZheEn}}

PDF(1051 KB)
PDF(1051 KB)
Front. Med. ›› 2023, Vol. 17 ›› Issue (6) : 1068-1079. DOI: 10.1007/s11684-023-1037-3
REVIEW

Small-molecule anti-COVID-19 drugs and a focus on China’s homegrown mindeudesivir (VV116)

  • {{article.zuoZheEn}}
Author information +
History +

Highlights

{{article.highlightEn}}

Abstract

{{article.abstractEn}}

Author summary

{{article.authorSummayEn}}

Keywords

Cite this article

EndNote

Ris (Procite)

Bibtex

Download citation ▾
{{article.zuoZheEn_L}}. {{article.titleEn}}. Front. Med., 2023, 17(6): 1068‒1079 https://doi.org/10.1007/s11684-023-1037-3

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

RIGHTS & PERMISSIONS

{{article.copyright.year}} {{article.copyright.holder}}
PDF(1051 KB)

Accesses

Citations

Detail
Sections
Recommended

/

〈 〉